Pheromonicin Biotech
Latest round
- Series A
Last raised
- Jun 2010
Total raised
- Undisclosed
Investors
- 1
About Pheromonicin Biotech
Founded in 2008, Pheromonicin Biotech, headquartered in Beijing, China, focuses on antibiotic development.Pheromonicin Biotech Corporation specializes in the research and development of innovative antibiotic solutions, primarily through its flagship product, Pheromonicin. This antibiotic targets drug-resistant bacteria by creating lethal ion channels in bacterial cell membranes, disrupting cellular integrity and causing bacterial death. The company addresses major health threats from antibiotic-resistant infections, particularly within healthcare settings. Pheromonicin and its derivatives are being developed for various applications including the treatment of antibiotic-resistant infections, anti-fungal infections, cancer research, and agricultural purposes.Pheromonicin Biotech Corporation generates revenue through strategic partnerships, licensing agreements, and direct sales of its products. The company licenses its proprietary technology and products to established pharmaceutical firms, which subsequently sell the developed medications to healthcare providers and end-users. Collaborations with research institutions for joint development initiatives further enhance its revenue streams.Pheromonicin Biotech plans to enhance its product portfolio by launching new antibiotic solutions and innovative applications in the near future. The company targets expansion into key markets, focusing on the United States, Europe, and Asia-Pacific regions by the end of 2023.
Who invested in Pheromonicin Biotech
1 investor across 1 round
See all investors in Pheromonicin Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 1, 2010
Amount
Undisclosed
Investors
Questions about Pheromonicin Biotech
Who invested in Pheromonicin Biotech?
Pheromonicin Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pheromonicin Biotech raised?
Pheromonicin Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pheromonicin Biotech last raise money?
Pheromonicin Biotech's most recent round on record is a Series A, in Jun 2010.
What does Pheromonicin Biotech do?
Founded in 2008, Pheromonicin Biotech, headquartered in Beijing, China, focuses on antibiotic development.
Where is Pheromonicin Biotech headquartered?
Pheromonicin Biotech is headquartered in Beijing, China.
Which VCs invest in companies like Pheromonicin Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Pheromonicin Biotech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Pheromonicin Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.